Novel approaches to target cancer’s epigenome
Designing next-generation small-molecule inhibitors that reprogram cancer cells, by targeting epigenetic mechanism such as DNA, RNA and/or histone modifications, with potential to combine with other therapies to deepen response and overcome resistance mechanisms